88IV - PR Newswire Asia's news


Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins) Treatment with ZEGFROVY ® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over platinum-containing chemo doublet WU-KONG 28 ... 2026-03-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Quality Protein No Longer a Luxury? Angel Yeast Shows How at FIC 2026 SHANGHAI , March 20, 2026 /PRNewswire/ -- Angel Yeast (SH600298) showcased its latest yeast protein R&D achievements and progress in global applications at FIC 2026 from March 17-19, 2026, ... 2026-03-20T Beverages Biotechnology Computer/Electronics
Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations SHANGHAI , March 20, 2026 /PRNewswire/ -- Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting period, the Company recorded revenue of RMB 6.6666 ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development WILMINGTON, Del. , March 20, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised $787 million in financing ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability SHANGHAI and HONG KONG , March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) today announced its full-year results for the period ending December 31, ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Tescan Opens New Demo Lab in Korea to Support Semiconductor Failure Analysis, Reliability, and Academic Research Across Asia-Pacific Integrated demo lab and office site brings demonstrations, training, and workflow support closer to semiconductor and academic users across APAC . ... 2026-03-20T Biotechnology Computer/Electronics Semiconductors
Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs SUZHOU, China and MÖLNDAL, Sweden , March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) had ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences SINGAPORE , March 20, 2026 /PRNewswire/ -- MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the ... 2026-03-20T Biotechnology Education Health Care/Hospital Higher Education
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016 SUZHOU, China , March 20, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session SHANGHAI , March 20, 2026 /PRNewswire/ -- D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five abstracts ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology